Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganciclovir Eye Drops for Cytomegalovirus Corneal Endotheliitis
jRCTs021180030Completed
- Start
- Mar 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ganciclovir. Primary endpoint: Corneal condition. Started Mar 2016; status: completed.
02
Drugs
ganciclovir
Beyond the preview
Go deeper on jRCTs021180030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021180030.